Branded

​​​​​​​Ready-to-administer calcium gluconate in non-PVC, non-DEHP containers is designed to promote safety and convenience.

Veklury (remdesivir) is the first and only approved treatment for pediatric patients under age 12 years old with COVID-19.

With a ​​​​​​​prescription from their healthcare provider, Rite Aid customers have increased access to Paxlovid and Molnupiravir.

Ztal​​​​​​​my is the first and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder in patients aged 2 years old and older, the company said.

Triumeq, the first dispersible single-tablet regimen containing dolutegravir, increases age-appropriate treatment options for children living with HIV, the company said.

Ozempic will be available in 0.5 mg, 1 mg and 2 mg to help people with Type 2 diabetes reach their blood sugar (A1C) goal, including those with a higher A1C who have been unable to meet their A1C target.

The expanded indication for the first and only complete long-acting HIV regimen provides an option with as few as six dosing days per year for virologically suppressed young people living with HIV.

Tlando is an oral treatment for testosterone replacement therapy indicated for conditions associated with a deficiency or absence of endogenous testosterone or hypogonadism in adult males.